Patients on injectable diacetylmorphine maintenance have low bone mass

Drug and Alcohol Review

Volumn 30, Issue 6, 2011, Pages 577-582

  Dürsteler Macfarland, Kenneth M ^a,b   Kowalewski, Roland ^b   Bloch, Nicole ^a   Wiesbeck, Gerhard A ^a   Kraenzlin, Marius E ^c   Stohler, Rudolf ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Bone mineral density; Diacetylmorphine; Dual energy X ray absorptiometry; Heroin dependence; Osteoporosis

Indexed keywords

DIAMORPHINE; NARCOTIC AGENT;

ADULT; ARTICLE; BONE DENSITY; CROSS-SECTIONAL STUDY; DRUG EFFECT; FEMALE; FEMUR; HEROIN DEPENDENCE; HUMAN; LUMBAR VERTEBRA; MALE; OSTEOPOROSIS; RADIOGRAPHY;

ADULT; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; FEMUR; HEROIN; HEROIN DEPENDENCE; HUMANS; LUMBAR VERTEBRAE; MALE; NARCOTICS; OSTEOPOROSIS;

EID: 80155187484     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2010.00242.x     Document Type: Article

References (46)

1. NIH Consensus Development Panel on Osteoporosis. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-95.
2. Cole ZA, Dennison EM, Cooper C. Osteoporosis epidemiology update. Curr Rheumatol Rep 2008;10:92-6.
3. Rizzoli R, Bonjour JP, Ferrari SL. Osteoporosis, genetics and hormones. J Mol Endocrinol 2001;26:79-94.
4. Duncan EL, Brown MA. Genetic studies in osteoporosis-the end of the beginning. Arthritis Res Ther 2008;10:214.
5. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 2005;115:3318-25.
6. Ebeling PR. Osteoporosis in men. N Engl J Med 2008;358:1474-82.
7. Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat 2005;28:321-9.
8. Kreek MJ, Vocci FJ. History and current status of opioid maintenance treatments: blending conference session. J Subst Abuse Treat 2002;23:93-105.
9. Brugal MT, Domingo-Salvany A, Puig R, Barrio G, Garcia de Olalla P, de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction 2005;100:981-9.
10. Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry 2001;58:503-8.
11. Rosen D, Smith ML, Reynolds CF 3rd. The prevalence of mental and physical health disorders among older methadone patients. Am J Geriatr Psychiatry 2008;16:488-97.
12. Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Santoro N, Schoenbaum EE. HIV infection and bone mineral density in middle-aged women. Clin Infect Dis 2006;42:1014-20.
13. Kim TW, Alford DP, Malabanan A, Holick MF, Samet JH. Low bone density in patients receiving methadone maintenance treatment. Drug Alcohol Depend 2006;85:258-62.
14. Schoenbaum EE, Hartel D, Lo Y, etal. HIV Infection, drug use, and onset of natural menopause. Clin Infect Dis 2005;41:1517-24.
15. Vuong C, Van Uum SH, O'Dell LE, Lutfy K, Friedman TC. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 2010;31:98-132.
16. Kreek MJ. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann NY Acad Sci 2000;909:186-216.
17. Schluger JH, Bart G, Green M, Ho A, Kreek MJ. Corticotropin-releasing factor testing reveals a dose-dependent difference in methadone maintained vs control subjects. Neuropsychopharmacology 2003;28:985-94.
18. Tennant F, Shannon JA, Nork JG, Sagherian A, Berman M. Abnormal adrenal gland metabolism in opioid addicts: implications for clinical treatment. J Psychoactive Drugs 1991;23:135-49.
19. Dursteler-MacFarland KM, Stohler R, Moldovanyi A, etal. Complaints of heroin-maintained patients: a survey of symptoms ascribed to diacetylmorphine. Drug Alcohol Depend 2006;81:231-9.
20. Novick DM, Kreek MJ. Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients. Addiction 2008;103:905-18.
21. Sendi P, Hoffmann M, Bucher HC, etal. Intravenous opiate maintenance in a cohort of injecting drug addicts. Drug Alcohol Depend 2003;69:183-8.
22. Wittchen HU, Zaudig M, Fydrich T. Strukturiertes Klinisches Interview für DSM-IV (Achse I und II). Göttingen: Hogrefe-Verlag, 1997.
23. Pedrazzoni M, Vescovi PP, Maninetti L, etal. Effects of chronic heroin abuse on bone and mineral metabolism. Acta Endocrinol (Copenh) 1993;129:42-5.
24. Wilczek H, Stepan J. [Bone metabolism in individuals dependent on heroin and after methadone administration]. Cas Lek Cesk 2003;142:606-8.
25. Kolarzyk E, Chrostek Maj J, Pach D, Janik A, Kwiatkowski J, Szurkowska M. Assessment of daily nutrition ratios of opiate-dependent persons before and after 4years of methadone maintenance treatment. Przegl Lek 2005;62:368-72.
26. Smit E, Graham NM, Tang A, Flynn C, Solomon L, Vlahov D. Dietary intake of community-based HIV-1 seropositive and seronegative injecting drug users. Nutrition 1996;12:496-501.
27. Srivastava A, Kahan M, Ross S. The effect of methadone maintenance treatment on alcohol consumption: a systematic review. J Subst Abuse Treat 2008;34:215-23.
28. Wurst FM, Dursteler-MacFarland KM, Auwaerter V, etal. Assessment of alcohol use among methadone maintenance patients by direct ethanol metabolites and self-reports. Alcohol Clin Exp Res 2008;32:1552-7.
29. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 1997;315:841-6.
30. Ward KD, Klesges RC. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int 2001;68:259-70.
31. MacInnis RJ, Cassar C, Nowson CA, etal. Determinants of bone density in 30- to 65-year-old women: a co-twin study. J Bone Miner Res 2003;18:1650-6.
32. Tamaki J, Iki M, Fujita Y, etal. Impact of smoking on bone mineral density and bone metabolism in elderly men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) study. Osteoporos Int 2010;Epub ahead of publication. DOI: 10.1007/s00198-010-1238-x
33. Zhang J, Chen F, Yun F, Chen J. Low level nicotine: a novel approach to reduce osteoporosis incidence. Med Hypotheses 2010;74:1067-8.
34. Orwell ES, Klein RF. Osteoporosis in men. Endocr Rev 1995;16:298-327.
35. Dursteler-MacFarland KM, Störmer R, Seifritz E, etal. Opioid-associated effects on oxygen saturation in humans. Addiction 2000;95:285-7.
36. Stohler R, Dursteler KM, Stormer R, etal. Rapid cortical hemoglobin deoxygenation after heroin and methadone injection in humans: a preliminary report. Drug Alcohol Depend 1999;57:23-8.
37. Chakkalakal DA. Alcohol-induced bone loss and deficient bone repair. Alcohol Clin Exp Res 2005;29:2077-90.
38. Tucker KL, Jugdaohsingh R, Powell JJ, etal. Effects of beer, wine and liquor intakes on bone mineral density in older men and women. Am J Clin Nutr 2009;89:1188-96.
39. Daniell HW. Opioid osteoporosis. Arch Intern Med 2004;164:338.
40. Abs R, Verhelst J, Maeyaert J, etal. Endocrine consequences of long-term Intrathecal administration of opioids. J Clin Endocrinol Metab 2000;85:2215-22.
41. Roberts LJ, Finch PM, Pullan PT, Bhagat CI, Price LM. Sex hormone suppression by intrathecal opioids: a prospective study. Clin J Pain 2002;18:144-8.
42. Peles E, Schreiber S, Naumovsky Y, Adelson M. Depression in methadone maintenance treatment patients: rate and risk factors. J Affect Disord 2007;99:213-20.
43. Misra M, Papakostas GI, Klibanski A. Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. J Clin Psychiatry 2004;65:1607-18.
44. Kinjo M, Setoguchi S, Schneeweiss S, Solomon DH. Bone mineral density in subjects using central nervous system-active medications. Am J Med 2005;118:1414.
45. Grant I, Adams KM, Carlin AS, Rennick PM, Judd LL, Schooff K. The collaborative neuropsychological study of polydrug users. Arch Gen Psychiatry 1978;35:1063-74.
46. Vitale S, van de Mheen D. Illicit drug use and injuries: a review of emergency room studies. Drug Alcohol Depend 2006;82:1-9.